Clinical Trial Update: Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating anakinra with or without dexamethasone in patients with smoldering or indolent multiple myeloma; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Smoldering Multiple Myeloma

Drugs mentioned

• Anakinra (anakinra)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2010-12-09